{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:08:21Z","timestamp":1777039701003,"version":"3.51.4"},"reference-count":29,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Programma di Ricerca Regione-Universit\u00e0 2010\u20132012-Area 1\u2014Strategic Research Programmes Regione Emilia-Romagna Progetto Triennale"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The laboratory diagnostics of primary biliary cholangitis (PBC) have substantially improved, thanks to innovative analytical opportunities, such as enzyme-linked immunosorbent assays (ELISA) and multiple immunodot liver profile tests, based on recombinant or purified antigens. This study aimed to identify the best diagnostic test combination to optimize PBC diagnosis. Between January 2014 and March 2017, 164 PBC patients were recruited at the hospitals of Parma, Modena, Reggio-Emilia, and Piacenza. Antinuclear antibodies (ANA) and anti-mitochondrial antibodies (AMA) were assayed by indirect immunofluorescence (IIF), ELISA, and immunodot assays (PBC Screen, MIT3, M2, gp210, and sp100). AMA-IIF resulted in 89.6% positive cases. Using multiple immunodot liver profiles, AMA-M2 sensitivity was 94.5%, while anti-gp210 and anti-sp100 antibodies were positive in 16.5% and 17.7% of patients, respectively. PBC screening yielded positive results in 94.5% of cases; MIT3, sp100, and gp210 were detected by individual ELISA test in 89.0%, 17.1%, and 18.9% of patients, respectively. The association of PBC screening with IIF-AMA improved the diagnostic sensitivity from 89.6% to 98.2% (p &lt; 0.01). When multiple immunodot liver profile testing was integrated with AMA-IIF, the diagnostic sensitivity increased from 89.1% to 98.8% (p &lt; 0.01). The combination of IIF with solid-phase methods significantly improved diagnostic efficacy in PBC patients.<\/jats:p>","DOI":"10.3390\/jcm11175238","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T20:52:51Z","timestamp":1662497571000},"page":"5238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimization of Laboratory Diagnostics of Primary Biliary Cholangitis: When Solid-Phase Assays and Immunofluorescence Combine"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9615-0086","authenticated-orcid":false,"given":"Federica","family":"Gaiani","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"},{"name":"Gastroenterology and Endoscopy Unit, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Minerba","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Chemistry and Hematology, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Picanza","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Chemistry and Hematology, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Russo","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Chemistry and Hematology, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Melegari","sequence":"additional","affiliation":[{"name":"Autoimmunity Unit, Department of Laboratory Medicine and Pathology, S. Agostino Estense Hospital, Via Giardini 1355, 41126 Baggiovara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"De Santis","sequence":"additional","affiliation":[{"name":"Autoimmunity Unit, Department of Laboratory Medicine and Pathology, S. Agostino Estense Hospital, Via Giardini 1355, 41126 Baggiovara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Trenti","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, S. Agostino Estense Hospital, Via Giardini 1355, 41126 Baggiovara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Belloni","sequence":"additional","affiliation":[{"name":"Unit of Clinical Immunology, Allergy and Advanced Biotechnologies, Azienda Unit\u00e0 Sanitaria Locale\u2014IRCCS of Reggio-Emilia, Viale Risorgimento 80, 42123 Reggio-Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Peveri","sequence":"additional","affiliation":[{"name":"Allergology Unit, Guglielmo da Saliceto Hospital, Via Giuseppe Taverna 49, 29121 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalia","family":"Aloe","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Chemistry and Hematology, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"},{"name":"Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Laghi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"},{"name":"Gastroenterology and Endoscopy Unit, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luigi","family":"de\u2019Angelis","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy"},{"name":"Gastroenterology and Endoscopy Unit, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bonaguri","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Chemistry and Hematology, University Hospital of Parma, Via Gramsci 14, 43126 Parma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol., 67, 145\u2013172.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.510300213","article-title":"Primary biliary cirrhosis once rare, now common in the United Kingdom?","volume":"30","author":"James","year":"1999","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwt308","article-title":"No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England","volume":"179","author":"McNally","year":"2014","journal-title":"Am. J. Epidemiol. 15"},{"key":"ref_5","first-page":"48","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the study of liver disease","volume":"114","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2018.05.008","article-title":"Evolution of our understanding of PBC","volume":"34\u201335","author":"Tanaka","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/08916930701619227","article-title":"Serum autoantibodies: A road map for the clinical hepatologist","volume":"41","author":"Meda","year":"2008","journal-title":"Autoimmunity"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/erm.11.82","article-title":"Antinuclear antibodies as ancillary markers in primary biliary cirrhosis","volume":"12","author":"Granito","year":"2012","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14737159.2016.1217159","article-title":"Molecular diagnostic testing for primary biliary cholangitis","volume":"16","author":"Gatselis","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2249.2002.01719.x","article-title":"Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders","volume":"127","author":"Muratori","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","article-title":"Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: Study of 100 sera and review of the literature","volume":"42","author":"Bizzaro","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12026-014-8587-z","article-title":"Autoimmune diagnostics: The technology, the strategy and the clinical governance","volume":"61","author":"Bizzaro","year":"2015","journal-title":"Immunol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17530059.2.6.621","article-title":"Molecular diagnostics of primary biliary cirrhosis","volume":"2","author":"Rigopoulou","year":"2008","journal-title":"Expert Opin. Med. Diagn."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2016.11.021","article-title":"Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis","volume":"464","author":"Han","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4254\/wjh.v8.i33.1419","article-title":"Recent advances in the diagnosis and treatment of primary biliary cholangitis","volume":"8","author":"Huang","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: Model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102389","DOI":"10.1016\/j.autrev.2019.102389","article-title":"Association of solid-phase assays to the indirect immunofluorescence in primary biliary cholangitis diagnosis: Results of an Italian multicenter study","volume":"18","author":"Bonaguri","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/sim.4780101206","article-title":"Statistics in medical journals: Developments in the 1980s","volume":"10","author":"Altman","year":"1991","journal-title":"Stat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12026-016-8838-2","article-title":"Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: Is it possible to predict the course of the disease?","volume":"65","author":"Alfano","year":"2017","journal-title":"Immunol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2014.08.024","article-title":"Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay","volume":"438","author":"Villalta","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: An IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.autrev.2017.12.007","article-title":"The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases","volume":"17","author":"Bizzaro","year":"2018","journal-title":"Autoimmun. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:23:39Z","timestamp":1760142219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/17\/5238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":29,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["jcm11175238"],"URL":"https:\/\/doi.org\/10.3390\/jcm11175238","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}